Explore All 789 Divestiture Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | April 27, 2023 |
| Target | Inke |
| Sector | Life Science |
| Buyer(s) | Keensight Capital |
| Sellers(s) | neuraxpharm |
| Deal Type | Divestiture |
FILTER BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2000 |
| PE ASSETS | 5.5B EUR |
| Size | Mega |
| Type | Sector Agnostic |
Keensight Capital is a private equity investment firm focused on majority and minority growth capital investments in Western European companies. Keensight makes equity investments in a number of situations including the provision of capital to finance growth, either organically or through acquisitions, or the buying out of existing shareholders. The Firm looks to invest €10 to €600 million and will consider business with up to €400 million in revenue. Keensight Capital was formed in 2000 and is based in Paris.
| Deal Context for Buyer | # |
|---|---|
| Overall | 43 of 54 |
| Sector: Life Science | 8 of 9 |
| Type: Divestiture | 4 of 4 |
| Country: Spain | 3 of 3 |
| Year: 2023 | 2 of 6 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-01-26 |
Onventis
Stuttgart, Germany Onventis is a manufacturer of on-demand E-Procurement and SRM software. The company offers integrated software and the pertaining service to medium-sized and large companies. Onventis was founded in 2000 and is based in Stuttgart, Germany. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-06-27 |
Nomios
Zoeterwoude, Netherlands Nomios is a Network and Security Integrator dedicated to the supply, implementation, and maintenance of next-generation networks for service providers and network operators. Nomios offers a wide range of services such as consultancy, integration, and managed services to service providers and network operators. Nomios was founded in 2004 and is based in Zoeterwoude, Netherlands. |
Buy | - |
| Category | Company |
|---|---|
| Founded | 1985 |
| Sector | Life Science |
| Revenue | 460M EUR (2019) |
neuraxpharm is a provider of generic pharmaceutical products for the treatment of disorders of the central nervous system (CNS). neuraxpharm was formed in 1985 and is based in Langenfeld, Germany.
| Deal Context for Seller | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science | 1 of 1 |
| Type: Divestiture | 1 of 1 |
| Country: Spain | 1 of 1 |
| Year: 2023 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-03-08 |
Brain Therapeutics
Athens, Greece Brain Therapeutics specializes in the in-licensing and commercialization of pharmaceutical products in the CNS therapy area to address the unmet medical needs of patients with mental, neurological, neurodevelopmental, or neurodegenerative disorders, as well as anesthesia and pain. Brain Therapeutics is headquartered in Athens, Greece. |
Buy | - |
